UK markets close in 3 hours 52 minutes

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
44.29+0.94 (+2.17%)
At close: 04:00PM EDT
44.29 0.00 (0.00%)
After hours: 05:04PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
118,370
234,195
118,719
147,703
-
Other short-term investments
217,630
128,599
622,203
220,310
-
Total cash
336,000
362,794
740,922
368,013
-
Net receivables
240,001
188,884
92,115
98,733
-
Inventory
127,601
100,123
53,908
60,747
-
Other current assets
48,613
45,024
40,482
28,274
-
Total current assets
746,424
739,013
926,287
554,764
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
94,605
90,326
21,894
22,175
-
Accumulated depreciation
-19,661
-14,756
-13,100
-11,582
-
Net property, plant and equipment
74,944
75,570
8,794
10,593
-
Goodwill
416,821
409,049
0
-
-
Intangible assets
472,879
546,652
-
-
-
Other long-term assets
17,816
26,801
13,914
14,567
-
Total non-current assets
986,846
1,102,498
178,142
25,160
-
Total assets
1,733,270
1,841,511
1,104,429
579,924
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
13,334
89,419
397,228
19,542
Accounts payable
11,816
17,693
1,541
1,928
-
Accrued liabilities
100,678
99,762
24,441
20,483
-
Deferred revenues
-
3,246
1,746
1,746
4,012
Total current liabilities
112,494
130,789
117,147
421,385
-
Non-current liabilities
Long-term debt
1,499,248
1,492,766
787,255
-
383,045
Deferred revenues
-
2,253
2,530
4,026
1,247
Other long-term liabilities
37,720
48,158
544
3,466
-
Total non-current liabilities
1,536,968
1,540,924
790,329
7,492
-
Total liabilities
1,649,462
1,671,713
907,476
428,877
-
Stockholders' equity
Common stock
127
135
138
135
-
Retained earnings
90,550
143,217
-58,912
-474,593
-
Accumulated other comprehensive income
-9,278
-922
-620
22
-
Total stockholders' equity
83,808
169,798
196,953
151,047
-
Total liabilities and stockholders' equity
1,733,270
1,841,511
1,104,429
579,924
-